With World share markets in decline the outlook for a financial planning business looks poor. Think they will struggle to make a profit for the year.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025